RT @jclinicalinvest: On the Cover: Inhibiting isocitrate dehydrogenase 1 mutant glioma: https://t.co/EQE77drBLL Image: small molecule inhib…
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
Inhibiting isocitrate dehydrogenase 1 mutant glioma. Super exciting and impactful!
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
RT @RajKhajur: Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice https://t.co/OJe4UZ…
RT @jclinicalinvest: On the Cover: Inhibiting isocitrate dehydrogenase 1 mutant glioma: https://t.co/EQE77drBLL Image: small molecule inhib…
RT @jclinicalinvest: On the Cover: Inhibiting isocitrate dehydrogenase 1 mutant glioma: https://t.co/EQE77drBLL Image: small molecule inhib…
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
RT @jclinicalinvest: On the Cover: Inhibiting isocitrate dehydrogenase 1 mutant glioma: https://t.co/EQE77drBLL Image: small molecule inhib…
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice https://t.co/OJe4UZwwmj
RT @jclinicalinvest: On the Cover: Inhibiting isocitrate dehydrogenase 1 mutant glioma: https://t.co/EQE77drBLL Image: small molecule inhib…
RT @jclinicalinvest: On the Cover: Inhibiting isocitrate dehydrogenase 1 mutant glioma: https://t.co/EQE77drBLL Image: small molecule inhib…
RT @UMRogelCancer: Kudos to @castro2355_mg & team for #glioma research that landed the cover of this month's @jclinicalinvest! https://t.co…
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
RT @jclinicalinvest: On the Cover: Inhibiting isocitrate dehydrogenase 1 mutant glioma: https://t.co/EQE77drBLL Image: small molecule inhib…
RT @jclinicalinvest: On the Cover: Inhibiting isocitrate dehydrogenase 1 mutant glioma: https://t.co/EQE77drBLL Image: small molecule inhib…
Congrats @castro2355_mg !! Beautiful cover art by @Ella_Maru
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
RT @UMRogelCancer: Kudos to @castro2355_mg & team for #glioma research that landed the cover of this month's @jclinicalinvest! https://t.co…
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
Kudos to @castro2355_mg & team for #glioma research that landed the cover of this month's @jclinicalinvest!
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
El trabajo más reciente de mí queridísima @castro2355_mg en LA TAPA DE JCI!!! Me vuelvo loca! Léanlo que está genial!
RT @jclinicalinvest: On the Cover: Inhibiting isocitrate dehydrogenase 1 mutant glioma: https://t.co/EQE77drBLL Image: small molecule inhib…
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
RT @castro2355_mg: So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less a…
So proud of this work, which will pave the way for phase 1 trials for mutant IDH1 gliomas. These brain tumors are less aggressive than wild type IDH1 gliomas, nevertheless they always recurr causing the demise of the patients. Kudos to the first author Pad
On the Cover: Inhibiting isocitrate dehydrogenase 1 mutant glioma: https://t.co/EQE77drBLL Image: small molecule inhibition of 2HG production promoted T cell response to glioma, which led to enhanced immunological memory & survival. Credit:@Ella_Maru @
New Publication from the @castro2355_mg and #Lowenstein_Lab! "Inhibition of 2-Hydroxyglutarate Elicits Metabolic-reprograming and Mutant IDH1 Glioma Immunity in Mice" has been published in the Journal of @jclinicalinvest! Read more: https://t.co/cgTxEOGi8
@castro2355_mg https://t.co/mh1w2fwQKI Congratulations Maria and colleagues for this exciting study on the immune microenvironment in IDH mutant gliomas!
JCI - Inhibition of 2-Hydroxyglutarate Elicits Metabolic-reprograming and Mutant IDH1 Glioma Immunity in Mice https://t.co/auAxg1b5Ih
Dr. Maria Castro (@castro2355_mg) at @umichmedicine demonstrates that metabolic reprogramming elicits anti-mIDH1 #glioma immunity. 📌Abstract: https://t.co/Yk7xuWX1TT 📌Press Release: https://t.co/zTX7JEjQaE
RT @umichneuro: If you haven't read this incredible work by @castro2355_mg , et al., you're missing out! #glioblastoma #GBM #womeninstem
If you haven't read this incredible work by @castro2355_mg , et al., you're missing out! #glioblastoma #GBM #womeninstem
RT @weldeiry: JCI - Inhibition of 2-Hydroxyglutarate Elicits Metabolic-reprograming and Mutant IDH1 Glioma Immunity in Mice https://t.co/1I…
JCI - Inhibition of 2-Hydroxyglutarate Elicits Metabolic-reprograming and Mutant IDH1 Glioma Immunity in Mice https://t.co/1I3SGEyKRJ
RT @castro2355_mg: JCI - Inhibition of 2-Hydroxyglutarate Elicits Metabolic-reprograming and Mutant IDH1 Glioma Immunity in Mice. https://t…
RT @castro2355_mg: JCI - Inhibition of 2-Hydroxyglutarate Elicits Metabolic-reprograming and Mutant IDH1 Glioma Immunity in Mice. https://t…
RT @castro2355_mg: JCI - Inhibition of 2-Hydroxyglutarate Elicits Metabolic-reprograming and Mutant IDH1 Glioma Immunity in Mice. https://t…
RT @castro2355_mg: JCI - Inhibition of 2-Hydroxyglutarate Elicits Metabolic-reprograming and Mutant IDH1 Glioma Immunity in Mice. https://t…
Wow... fantastic work! Congratulations to @castro2355_mg!
RT @castro2355_mg: JCI - Inhibition of 2-Hydroxyglutarate Elicits Metabolic-reprograming and Mutant IDH1 Glioma Immunity in Mice. https://t…
Very interesting study: targeting tumor driving mutated Krebs cycle enzyme (idh1) not only impacts on tumor cells differentiation but also reprograms antitumor immunity. Epigenetic regulation of immunity by tumor derived metabolites? That's what we will st
Imponente articulo de @castro2355_mg y colaboradores sobre el bloqueo de IDH1 mutada en la respuesta del glioma a la terapia tradicional y la inmunoterapia. Muchas felicidades, Maria y Padma!
RT @castro2355_mg: JCI - Inhibition of 2-Hydroxyglutarate Elicits Metabolic-reprograming and Mutant IDH1 Glioma Immunity in Mice. https://t…
RT @castro2355_mg: JCI - Inhibition of 2-Hydroxyglutarate Elicits Metabolic-reprograming and Mutant IDH1 Glioma Immunity in Mice. https://t…
RT @castro2355_mg: JCI - Inhibition of 2-Hydroxyglutarate Elicits Metabolic-reprograming and Mutant IDH1 Glioma Immunity in Mice. https://t…
RT @castro2355_mg: JCI - Inhibition of 2-Hydroxyglutarate Elicits Metabolic-reprograming and Mutant IDH1 Glioma Immunity in Mice. https://t…
RT @castro2355_mg: JCI - Inhibition of 2-Hydroxyglutarate Elicits Metabolic-reprograming and Mutant IDH1 Glioma Immunity in Mice. https://t…
RT @castro2355_mg: JCI - Inhibition of 2-Hydroxyglutarate Elicits Metabolic-reprograming and Mutant IDH1 Glioma Immunity in Mice. https://t…
JCI - Inhibition of 2-Hydroxyglutarate Elicits Metabolic-reprograming and Mutant IDH1 Glioma Immunity in Mice. https://t.co/UvljvPyLA3 Very proud of our collaborative paper @umichneuro @umichmedicine @UMRogelCancer . Thank you @CelinaKleer J Moon, A Schwe
Read the study: https://t.co/GLRIVHxshP